MedTrace Logo

A Trial of Dextromethorphan for Treatment of Major Depressive Disorder

NCT02860962 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-10-25

No results posted yet for this study

Summary

A proof-of-concept study to determine the antidepressant potential of Dextromethorphan for treating depression associated with Major Depressive Disorder in inpatients.

Conditions

Interventions

DRUG

Dextromethorphan Hydrobromide

Dose as a single capsule preparation formulated by the Investigational Drug Service of MUSC specifically for the purposes of this trial.

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Sudie E. Back, Ph.D. · Director of Drug and Alcohol Research Track at the Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02860962 on ClinicalTrials.gov